Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.
Vynckier P, De Sutter J, De Pauw M, Vandekerckhove H, De Backer G, Vervaet P, Deweerdt N, Dendale P, Persu A, Janssen A, Chenu P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D; EUROASPIRE V Investigators Group; EUROASPIRE IV.
Vynckier P, et al. Among authors: de smedt d, de bacquer d, de sutter j, de pauw m, de backer g.
Acta Cardiol. 2023 Jul;78(5):607-613. doi: 10.1080/00015385.2023.2169439. Epub 2023 Feb 13.
Acta Cardiol. 2023.
PMID: 36779380